These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
686 related articles for article (PubMed ID: 28376231)
1. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12). Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A; J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231 [TBL] [Abstract][Full Text] [Related]
2. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients. Kecke S; Ernst J; Einenkel J; Singer S; Hinz A J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation. Weis J; Wirtz MA; Tomaszewski KA; Hammerlid E; Arraras JI; Conroy T; Lanceley A; Schmidt H; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Harle A; Flechtner HH; Bottomley A; Psychooncology; 2019 Aug; 28(8):1753-1761. PubMed ID: 31225669 [TBL] [Abstract][Full Text] [Related]
4. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Weis J; Arraras JI; Conroy T; Efficace F; Fleissner C; Görög A; Hammerlid E; Holzner B; Jones L; Lanceley A; Singer S; Wirtz M; Flechtner H; Bottomley A Psychooncology; 2013 May; 22(5):1002-7. PubMed ID: 22565359 [TBL] [Abstract][Full Text] [Related]
5. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26. Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B; BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889 [TBL] [Abstract][Full Text] [Related]
6. Fatigue in the general population: German normative values of the EORTC QLQ-FA12. Hinz A; Weis J; Brähler E; Mehnert A Qual Life Res; 2018 Oct; 27(10):2681-2689. PubMed ID: 29909484 [TBL] [Abstract][Full Text] [Related]
7. Fatigue in breast cancer patients: psychometric evaluation of the fatigue questionnaire EORTC QLQ-FA13. Fuhrmann K; Mehnert A; Geue K; Hinz A Breast Cancer; 2015 Nov; 22(6):608-14. PubMed ID: 24633470 [TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer. Friedrich M; Nowe E; Hofmeister D; Kuhnt S; Leuteritz K; Sender A; Stöbel-Richter Y; Geue K Health Qual Life Outcomes; 2018 Jun; 16(1):125. PubMed ID: 29903021 [TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ; Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338 [TBL] [Abstract][Full Text] [Related]
10. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB; Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466 [TBL] [Abstract][Full Text] [Related]
11. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore. Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803 [TBL] [Abstract][Full Text] [Related]
12. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191 [TBL] [Abstract][Full Text] [Related]
13. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients. Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480 [TBL] [Abstract][Full Text] [Related]
14. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study. Halkett GKB; Wigley CA; Aoun SM; Portaluri M; Tramacere F; Livi L; Detti B; Arcangeli S; Lund JA; Kristensen A; McFadden N; Grun A; Bydder S; Sackerer I; Greimel E; Spry N; Radiat Oncol; 2018 Aug; 13(1):162. PubMed ID: 30157890 [TBL] [Abstract][Full Text] [Related]
15. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module. Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847 [TBL] [Abstract][Full Text] [Related]
16. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors. Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917 [TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the EORTC QLQ-C30 in Uganda. Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718 [TBL] [Abstract][Full Text] [Related]
18. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D; Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652 [TBL] [Abstract][Full Text] [Related]
19. Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients. Shen MH; Chen LP; Ho TF; Shih YY; Huang CS; Chie WC; Huang CC BMC Cancer; 2018 Apr; 18(1):353. PubMed ID: 29606101 [TBL] [Abstract][Full Text] [Related]
20. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction. Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT; Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]